Skip to Content
  • Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..

Current Oncology, Volume 27, Issue 5

2020 October - 21 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (21)

  • Article
  • Open Access
14 Citations
1,560 Views
6 Pages

Prognostic Utility of Neutrophil-to-Lymphocyte Ratio in Patients with Metastatic Colorectal Cancer Treated Using Different Modalities

  • G. Nogueira-Costa,
  • I. Fernandes,
  • R. Gameiro,
  • J. Gramaça and ,
  • A.T. Xavier and
  • I. Pina
  • + 1 author+ 0 author

1 October 2020

Introduction: Inflammation is a critical component in carcinogenesis. The neutrophil-to-lymphocyte ratio (nlr) has been retrospectively studied as a biomarker of prognosis in metastatic colorectal cancer (mcrc). Compared with a low nlr, a high nlr is...

  • Article
  • Open Access
5 Citations
1,639 Views
6 Pages

Diagnostic Patterns of Non-Small-Cell Lung Cancer at Princess Margaret Cancer Centre

  • M. Nadjafi,
  • M.R. Sung,
  • G.D.C. Santos,
  • L.W. Le and ,
  • D.M. Hwang,
  • M.S. Tsao and
  • N.B. Leighl
  • + 2 authors+ 0 author

1 October 2020

Background: Accurate classification of lung cancer subtypes has become critical in tailoring lung cancer treatment. Our study aimed to evaluate changes in diagnostic testing and pathologic subtyping of advanced non-small-cell lung cancer (NSCLC) over...

  • Article
  • Open Access
6 Citations
1,453 Views
7 Pages

Nodal Staging Affects Adjuvant Treatment Choices in Elderly Patients with Clinically Node-Negative, Estrogen Receptor–Positive Breast Cancer

  • A. Laws,
  • R. Cheifetz,
  • R. Warburton,
  • C.E. McGahan and ,
  • J.S. Pao,
  • U. Kuusk,
  • C. Dingee,
  • M.L. Quan and
  • E. McKevitt
  • + 4 authors+ 0 author

1 October 2020

Background: In response to Choosing Wisely recommendations that sentinel lymph node biopsy (slnb) should not be routinely performed in elderly patients with node-negative (cN0), estrogen receptor–positive (er+) breast cancer, we sought to evaluate ho...

  • Article
  • Open Access
10 Citations
1,736 Views
6 Pages

A Clinical Investigation of the Association between Perioperative Oral Management and Prognostic Nutritional Index in Patients with Digestive and Urinary Cancers

  • H. Otagiri,
  • S. Yamadav,
  • M. Hashidume,
  • A. Sakurai and ,
  • M. Morioka,
  • E. Kondo,
  • H. Sakai and
  • H. Kurita
  • + 3 authors+ 0 author

1 October 2020

Background: The prognostic nutritional index (PNI) is a simple metric calculated using serum albumin and the peripheral lymphocyte count. It was reported that a low PNI score is significantly associated with major postoperative complications and poor...

  • Article
  • Open Access
7 Citations
1,628 Views
7 Pages

1 October 2020

Background: In June 2016, when the Parliament of Canada passed Bill C-14, the country joined the small number of jurisdictions that have legalized medical assistance in dying (maid). Since legalization, nearly 7000 Canadians have received maid, most...

  • Article
  • Open Access
3 Citations
1,692 Views
5 Pages

Canadian Perspective on Managing Multiple Myeloma during the COVID-19 Pandemic: Lessons Learned and Future Considerations

  • R. Foley,
  • R. Kaedbey,
  • K. Song,
  • C.P. Venner and ,
  • D. White,
  • S. Doucette,
  • A. Christofides and
  • D.E. Reece
  • + 3 authors+ 0 author

1 October 2020

The coronavirus disease 2019 (covid-19) pandemic caused by the novel severe acute respiratory syndrome coronavirus 2 has necessitated changes to the way patients with chronic diseases are managed. Given that patients with multiple myeloma are at incr...

  • Article
  • Open Access
3 Citations
1,916 Views
4 Pages

1 October 2020

Cancer is a hypercoagulable state with an associated increased risk of venous thromboembolism (vte) that is further amplified in individuals who undergo chemotherapy. Compared with patients having cancer alone or vte alone, patients who develop cance...

  • Case Report
  • Open Access
4 Citations
1,441 Views
4 Pages

Multicentric Chondrosarcoma Involving the Appendicular Skeleton: A Case Report and Literature Review

  • V. Aran,
  • W. Meohas,
  • A.C. de Sá Lopes,
  • L. Maciel Cabral and ,
  • A. Fortuna-Costa,
  • J.A. Matheus Guimarães and
  • M.E. Leite Duarte
  • + 2 authors+ 0 author

1 October 2020

Chondrosarcomas constitute the 3rd most common primary bone malignancy. These tumours grow slowly and rarely metastasize, usually having a good prognosis after surgery. Among patients registered and treated at the Brazilian National Institute of Trau...

  • Article
  • Open Access
7 Citations
2,200 Views
7 Pages

Osteopontin Level and Promoter Polymorphism in Patients with Metastatic Breast Cancer

  • M.A. Elbaiomy,
  • T. Akl,
  • R. Elhelaly,
  • W. El-Beshbishi and ,
  • M.S. El Ghonemy and
  • R. Elzehery
  • + 1 author+ 0 author

1 October 2020

Background: Cancer initiation typically occurs when a proto-oncogene’s coding region undergoes mutation, resulting in uncontrollable cell growth and division, or when a tumour suppressor gene’s coding region is affected by a mutation that inhibits ac...

  • Article
  • Open Access
13 Citations
1,782 Views
8 Pages

1 October 2020

Background: Quality of life (qol) is important for oncology patients, especially for those with late-stage disease. The present study was initiated to address the lack of published prospective data about the qol benefits of trifluridine/tipiracil (ft...

  • Article
  • Open Access
17 Citations
2,988 Views
8 Pages

Understanding Clinical Practice and Survival Outcomes in Patients with Unresectable Stage III Non-Small-Cell Lung Cancer in a Single Centre in Quebec

  • J. Agulnik,
  • G. Kasymjanova,
  • C. Pepe,
  • M. Hurry and ,
  • R.N. Walton,
  • L. Sakr,
  • V. Cohen,
  • M. Lecavalier and
  • D. Small
  • + 4 authors+ 0 author

1 October 2020

Methods: A retrospective cohort study considered patients 18 or more years of age diagnosed between January 2007 and May 2018 with unresectable stage iii non-small-cell lung cancer (nsclc) who received combined chemoradiation (crt). Survival was anal...

  • Article
  • Open Access
28 Citations
2,502 Views
11 Pages

Delay in Diagnosis of Patients with Head-and-Neck Cancer in Canada: Impact of Patient and Provider Delay

  • S. Kassirian,
  • A. Dzioba,
  • S. Hamel,
  • K. Patel and ,
  • A. Sahovaler,
  • D.A. Palma,
  • N. Read,
  • V. Venkatesan,
  • A.C. Nichols and
  • S.D. MacNeil
  • + 8 authors+ 3 authors

1 October 2020

Background: Head-and-neck cancers (hncs) often present at an advanced stage, leading to poor outcomes. Late presentation might be attributable to patient delays (reluctance to seek treatment, for instance) or provider delays (misdiagnosis, prolonged...

  • Article
  • Open Access
18 Citations
2,419 Views
8 Pages

Cigarette-Smoking Characteristics and Interest in Cessation in Patients with Head-and-Neck Cancer

  • M.S.C. Conlon,
  • S.A. Santi,
  • M.L. Meigs,
  • S.M. Davidson and
  • D. Saunders

1 October 2020

Purpose: Many patients diagnosed with head-and-neck cancer are current or former smokers. Despite the well-known adverse effects of smoking, continuation of smoking during cancer treatment is associated with reduced efficacy of that treatment and wit...

  • Article
  • Open Access
23 Citations
2,618 Views
9 Pages

1 October 2020

Background: Immune checkpoint inhibitors (icis), including inhibitors of PD-1, PD-L1, and ctla-4, are relatively novel therapies for lung cancer, although their use might be limited by gastrointestinal toxicity. The aim of the present study was to de...

  • Article
  • Open Access
12 Citations
1,815 Views
6 Pages

Reimbursement Recommendations for Cancer Drugs Supported by Phase II Evidence in Canada

  • Y.Y.R. Li,
  • H. Mai,
  • M.E. Trudeau,
  • N. Mittmann and ,
  • K. Chiasson,
  • K.K.W. Chan and
  • M.C. Cheung
  • + 2 authors+ 0 author

1 October 2020

Background: Phase ii data are increasingly being used as primary evidence for public reimbursement for oncologic drugs. We compared the frequency of reimbursement recommendations for phase ii and phase iii submissions and assessed for variables assoc...

  • Review
  • Open Access
18 Citations
3,103 Views
11 Pages

Strategies for the Delay of Surgery in the Management of Resectable Hepatobiliary Malignancies during the COVID-19 Pandemic

  • S. Bennett,
  • K. Søreide,
  • S. Gholami,
  • P. Pessaux and ,
  • C. Teh,
  • E. Segelov,
  • H. Kennecke,
  • H. Prenen,
  • S. Myrehaug and
  • J. Hallet
  • + 6 authors+ 1 author

1 October 2020

Objective: We aimed to review data about delaying strategies for the management of hepatobiliary cancers requiring surgery during the covid-19 pandemic. Background: Given the covid-19 pandemic, many jurisdictions, to spare resources, have limited acc...

  • Article
  • Open Access
6 Citations
2,282 Views
4 Pages

1 October 2020

Sarcoma treatment during the covid-19 pandemic is a new challenge. This patient population is often immunocompromised and potentially more susceptible to viral complications. Government guidelines highlight the need to minimize patient exposure to un...

  • Article
  • Open Access
14 Citations
2,952 Views
8 Pages

A Pan-Canadian Prospective Study of Young Women with Breast Cancer: The Rationale and Protocol Design for the RUBY Study

  • M.L. Quan,
  • I.A. Olivotto,
  • N.N. Baxter,
  • C.M. Friedenreich and ,
  • K. Metcalfe,
  • E. Warner,
  • K. MacLennan,
  • J.E. Stephen,
  • M.R. Akbari and
  • the RUBY site investigators
  • + 7 authors+ 2 authors

1 October 2020

Introduction: The understanding of the biology and epidemiology of, and the optimal therapeutic strategies for, breast cancer (bca) in younger women is limited. We present the rationale, design, and initial recruitment of Reducing the Burden of Breas...

XFacebookLinkedIn
Curr. Oncol. - ISSN 1718-7729